Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension
- 1 July 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 26 (1) , 143-149
- https://doi.org/10.1161/01.hyp.26.1.143
Abstract
Abstract Calcium channel antagonists differ by class in reported frequency of side effects that suggest reflex sympathoadrenal activation. Do such differences result from differential effects on autonomic and baroreflex function? The present study compared acute and chronic effects of two classes of calcium channel antagonists, the dihydropyridine type (felodipine) and the phenylalkylamine type (verapamil), on efferent sympathetic outflow and baroreflex slope in 15 essential hypertensive subjects. Blood pressure, heart rate, hemodynamics, and biochemistries were determined at baseline and after acute (first dose) and chronic (4 weeks) administration of the drugs versus placebo. Acutely, felodipine caused a greater decrease in blood pressure associated with a larger decline in systemic vascular resistance than the corresponding effects produced by verapamil. Chronically, there were similar, significant declines in blood pressure ( P =.001) and systemic vascular resistance ( P =.001) after each drug. Acutely, increased sympathetic activity after felodipine was suggested by reflex tachycardia (from 69±3 to 74±2 beats per minute, P =.014) and elevation of plasma norepinephrine (from 264±25 to 323±25 pg/mL, P =.037), whereas after verapamil the corresponding changes were closely similar to those after placebo. Chronically, verapamil suppressed sympathetic activity, as evidenced by a decrease in resting heart rate (from 76±2 to 69±3 beats per minute, P =.002), decrease in plasma norepinephrine (from 264±25 to 178±21 pg/mL, P <.001), decrease in chromogranin A (from 33.0±2.4 to 27.8±1.7 ng/mL, P <.001), and lessened response of mean arterial pressure ( P =.006) and heart rate ( P =.016) to phentolamine α-adrenergic blockade; after chronic felodipine, all of these variables were unchanged. Neither drug affected baroreflex slope. We conclude that felodipine and verapamil have qualitatively different, time-dependent actions on efferent sympathetic nervous system activity, actions that may in part explain the disparity in autonomic/hemodynamic side effect profiles of the dihydropyridine and phenylalkylamine classes of calcium channel antagonists.Keywords
This publication has 27 references indexed in Scilit:
- Chromogranin a correlates with norepinephrine release rateLife Sciences, 1992
- FelodipineDrugs, 1992
- Sustained‐Release Verapamil Formulations for Treating HypertensionThe Journal of Clinical Pharmacology, 1992
- Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophyThe American Journal of Cardiology, 1992
- Felodipine Clinical PharmacokineticsClinical Pharmacokinetics, 1991
- The effect of calcium channel blockers on the H+-ATPase and bioenergetics of catecholamine storage vesiclesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing.Hypertension, 1989
- Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonistsThe American Journal of Cardiology, 1986
- Mild High-Renin Essential HypertensionNew England Journal of Medicine, 1977
- Circulatory dynamics during the cold pressor testThe American Journal of Cardiology, 1965